Care Managers for Perinatal Depression (CMPD)

Summary

The investigators will evaluate effects of introducing the care manager on:

1. Patient receipt of timely diagnosis and initiation of treatment for major depression (diagnosis within 2 weeks of screening and treatment within 1 month of diagnosis); and
2. Patient continuity of care for depression across the transition of care from pregnancy to postpartum (within 4 months postpartum).

Conditions

• Depression
• Pregnancy

Interventions

OTHER

Intervention

Participants in the intervention arm will receive standard care plus the addition of a care manager. Care managers will function to provide culturally competent and linguistically appropriate support for the care of women identified as being at high risk for depression in pregnancy. Working with both the care providers and these study participants care managers will serve as connectors, coaches, collaborators, and negotiators working to overcome barriers to depression care delivery.

OTHER

Control

Standard of care: within the current care processes, a woman initiating prenatal care completes a depression risk assessment using a two-step approach. Women with high risk of depression are then scheduled for a separate visit with a member of the care team (a physician, psychologist, or other mental health provider) referred to as a "perinatal depression champion" for a timely formal diagnostic interview.

Sponsors & Collaborators

• University of Pennsylvania

  collaborator OTHER

• Robert Wood Johnson Foundation

  collaborator OTHER

• Lancaster General Hospital

  lead OTHER

Principal Investigators

• Stephen Ratcliffe, MD, MSPH · Lancaster General Hospital

• Ian M Bennett, MD, PhD · University of Pennsylvania

• Donna Cohen, MD, MS · Lancaster General Hospital

• Michael A Horst, PhD, MPHS, MS · Lancaster General Hospital

Study Design

Allocation

RANDOMIZED

Purpose

HEALTH_SERVICES_RESEARCH

Masking

NONE

Model

PARALLEL

Eligibility

Min Age

13 Years

Sex

FEMALE

Healthy Volunteers

No

Timeline & Regulatory

Start

2010-09-30

Primary Completion

2013-12-31

Completion

2013-12-31

Countries

• United States

Study Locations